Synthesis and evaluation of aporphine analogs containing C1 allyl isosteres at the h5-HT(2A) receptor
- PMID: 26475518
- PMCID: PMC4628873
- DOI: 10.1016/j.bmcl.2015.10.012
Synthesis and evaluation of aporphine analogs containing C1 allyl isosteres at the h5-HT(2A) receptor
Abstract
A series of C1 aporphine analogs related to compound 5 and that contain substituted allylic, alkynyl, nitrile, ester and benzyl groups was synthesized and evaluated for affinity at h5HT2A and α1A receptors in functional activity assays that measure calcium release. The presence of branched allylic substituent groups diminished affinity for the h5HT2A receptor. Likewise, the alkynyl, nitrile and ester derivatives evaluated displayed lower 5-HT2A receptor affinity as compared to 5. Hydrophobic, steric and electronic effects impact the affinity of p-substituted benzyl derivatives 8i-8k but in different ways. High hydrophobicity and size favor 5-HT2A affinity whereas, high electronegativity disfavors 5-HT2A affinity. p-Bromobenzyl analog 8k was identified as a 5-HT2A receptor selective ligand, with the highest 5-HT2A receptor affinity of any aporphine known to date. Most of the other analogs were selective for the 5-HT2A versus the α1A receptor. ChemScore binding energies from docking studies correlated qualitatively with the observed trends in affinity for 8i-8k, although the binding energies were not well differentiated quantitatively.
Keywords: 5-HT(2A); Adrenergic; Antagonist; Aporphine; Nantenine.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4628873/bin/nihms730949f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4628873/bin/nihms730949f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4628873/bin/nihms730949f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4628873/bin/nihms730949f4.gif)
![Scheme 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4628873/bin/nihms730949f5.gif)
Similar articles
-
Semisynthetic Transformations on (+)-Boldine Reveal a 5-HT2A/2CR Antagonist.J Nat Prod. 2022 Sep 23;85(9):2149-2158. doi: 10.1021/acs.jnatprod.2c00365. Epub 2022 Aug 24. J Nat Prod. 2022. PMID: 36001775 Review.
-
Overcoming Depression with 5-HT2A Receptor Ligands.Int J Mol Sci. 2021 Dec 21;23(1):10. doi: 10.3390/ijms23010010. Int J Mol Sci. 2021. PMID: 35008436 Free PMC article. Review.
-
C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.Bioorg Med Chem Lett. 2015 Sep 1;25(17):3451-4. doi: 10.1016/j.bmcl.2015.07.012. Epub 2015 Jul 11. Bioorg Med Chem Lett. 2015. PMID: 26227772 Free PMC article.
-
Evaluation of structural effects on 5-HT(2A) receptor antagonism by aporphines: identification of a new aporphine with 5-HT(2A) antagonist activity.Bioorg Med Chem Lett. 2014 Apr 1;24(7):1664-7. doi: 10.1016/j.bmcl.2014.02.066. Epub 2014 Mar 4. Bioorg Med Chem Lett. 2014. PMID: 24630561 Free PMC article.
-
New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine.Bioorg Med Chem. 2011 Oct 1;19(19):5861-8. doi: 10.1016/j.bmc.2011.08.019. Epub 2011 Aug 18. Bioorg Med Chem. 2011. PMID: 21900013 Free PMC article.
Cited by
-
Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity.Bioorg Med Chem Lett. 2020 Apr 15;30(8):127053. doi: 10.1016/j.bmcl.2020.127053. Epub 2020 Feb 20. Bioorg Med Chem Lett. 2020. PMID: 32107165 Free PMC article.
-
Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists.Medchemcomm. 2018 Feb 26;9(3):576-582. doi: 10.1039/c7md00629b. eCollection 2018 Mar 1. Medchemcomm. 2018. PMID: 30108948 Free PMC article.
-
Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist.Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):364-370. doi: 10.1016/j.ijpddr.2016.06.001. Epub 2016 Jun 23. Int J Parasitol Drugs Drug Resist. 2016. PMID: 27397763 Free PMC article.
References
-
- Sanger DJ, Soubrane C, Scatton B. Ann Pharm Fr. 2007;65:268. - PubMed
-
- Monti JM. Drugs Today (Barc) 2010;46:18. - PubMed
-
- Griebel G, Beeske S, Jacquet A, Laufrais C, Alonso R, Decobert M, Avenet P, Francon D. Neuropharmacology. 2013;70:19. - PubMed
-
- Teegarden BR, Al Shamma H, Xiong Y. Curr Top Med Chem. 2008;8:969. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information